PHARMACIST STEVE

An employee diverts 20,000 units of opiates … doesn’t say how the diversion was made … unless it was calling in Rxs to pharmacies while working at the office..  As insurance companies/Medicare/Medicaid keeps reducing payment for services.. the more ancillary staff that is needed to get the job done.. Prescribers are mostly in exam rooms with pts… employees are mostly directly unsupervised by the DEA registrant/prescriber.  There is no mention of any thing happening to the employee that diverted all those opiate doses.

I guess the employee didn’t have a “pot to piss in ” .. so did the DEA give the employee a “pass” for testifying against boss/prescriber ??

Oklahoma City Doctor Pays $40,000 to Settle
Civil Penalty Claims Involving Violations of
Controlled Substances Act
FOR IMMEDIATE RELEASE
July 7, 2014
Oklahoma City, Oklahoma — STANLEY K. ROGERS, D.O., who practices in Oklahoma City, Oklahoma, has agreed to pay $40,000 to the United States to settle civil penalty claims stemming from allegations that he violated the Controlled Substances Act, announced Sanford C. Coats, United States Attorney for the Western District of Oklahoma.

The Controlled Substances Act, 21 U.S.C. Sections 801 et seq. (“CSA”), was passed by Congress to combat the illegal distribution and abuse of controlled substances, including prescription medications. The CSA is enforced by the Drug Enforcement Administration’s (DEA) Office of Diversion Control, with a mission to prevent, detect, and investigate the diversion of controlled pharmaceuticals and listed chemicals from legitimate sources while ensuring an adequate and uninterrupted supply for legitimate medical, commercial, and scientific needs.

Under the CSA, medical providers registered with the DEA who purchase, distribute, dispense, transfer, or sell controlled substances must comply with inventory and documentation requirements. Regulations promulgated under the CSA require that each DEA registrant, maintain complete and accurate records of each substance manufactured, received, sold, delivered, dispensed or otherwise disposed of by the registrant. These requirements play a vital role in ensuring the appropriate handling, accounting, and distribution of controlled substances.

Violations of the record-keeping requirements subject DEA registrants to civil monetary penalties.

The United States alleged that between January 1, 2012, and February 4, 2014, at least one employee in Dr. Rogers’ office used his DEA registration number in order to obtain over 20,000 dosage units of Schedules III and IV controlled substances which were not for legitimate medical purposes.

It was alleged that Dr. Rogers failed to provide effective controls and procedures against theft and diversion, failed to maintain and review records of the dates, quantities received, dispensation, or inventories of controlled substances purchased using his DEA registration number.

In order to resolve the civil penalty claims against by the United States, Dr. Rogers agreed to pay $40,000 to the government In reaching this settlement, Dr. Rogers did not admit liability and the government did not make any concession regarding the legitimacy of the claims. The agreement allows the parties to avoid the delay, expense, inconvenience, and uncertainty involved in litigating the case.

This case was investigated by the Drug Enforcement Administration’s Oklahoma City District Office Diversion Group and was prosecuted by Assistant United States Attorney Ronald R. Gallegos.

Filed under: General Problems